Clinical trial
The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease
NCT03164005 is registered in ClinicalTrials.gov with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease
- Lead sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 20, 2017
- Completion date
- March 1, 2018
- Enrollment
- 194 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metabolic disease, obesity